Approval · Notice of Compliance 10 · 2004
ENDANTADINE: Notice of Compliance 10
Issued March 15, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10
- Date
- March 15, 2004
- Company
- Bristol-Myers Squibb CanadaSt-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antiviral agent, antiparkisonian agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ENDANTADINE | 02034468 | Cancelled Post Market |
Medicinal ingredients
- AMANTADINE HCL 100 MG per CAP